BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
Rahul Roychoudhuri(National Institutes of Health), Kiyoshi Hirahara(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Kambiz Mousavi(National Institutes of Health), David Clever(Center for Cancer Research), Christopher A. Klebanoff(National Institutes of Health), Michael Bonelli(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Giuseppe Sciumè(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Hossein Zare(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Golnaz Vahedi(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Bárbara Dema(National Institutes of Health), Zhiya Yu(National Institutes of Health), Hui Liu, Hayato Takahashi(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Mahadev Rao(Center for Cancer Research), Pawel Muranski(National Cancer Institute), Joseph G. Crompton(Center for Cancer Research), George A. Punkosdy(National Institute of Allergy and Infectious Diseases), Davide Bedognetti, Ena Wang, Victoria Hoffmann(Office of Research Services), Juan Rivera(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Francesco M. Marincola, Atsushi Nakamura(Tohoku University), Vittorio Sartorelli(National Institutes of Health), Yuka Kanno(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Luca Gattinoni(Center for Cancer Research), Akihiko Muto(Tohoku University), Kazuhiko Igarashi(Tohoku University), John J. O’Shea(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Nicholas P. Restifo(Center for Neuroscience and Regenerative Medicine)
Cited by 410